Page last updated: 2024-10-17

fosmidomycin and Escherichia coli Infections

fosmidomycin has been researched along with Escherichia coli Infections in 2 studies

fosmidomycin: from Streptomyces lavendulae; RN given refers to parent cpd; structure in second source
fosmidomycin : Propylphosphonic acid in which one of the hydrogens at position 3 is substituted by a formyl(hydroxy)amino group. An antibiotic obtained from Streptomyces lavendulae, it specifically inhibits DXP reductoisomerase (EC 1.1.1.267), a key enzyme in the non-mevalonate pathway of isoprenoid biosynthesis.

Escherichia coli Infections: Infections with bacteria of the species ESCHERICHIA COLI.

Research Excerpts

ExcerptRelevanceReference
"Antibiotic fosmidomycin will know as inhibitor of the nonmevalonate pathway of isoprenoid biosynthesis and as possible antimalarial drug, was shown to possess a certain protective effect on mice experimentally infected with tularemia, tiphus or coli-septicemia."3.72[Effect of fosfidomycin on development of various infections in mice]. ( Bakhteeva, IV; Biketov, SF; Biniukov, VI; Borzenkov, VN; Ostrovskiĭ, DN; Potapov, VD; Titareva, GM; Wiesner, J, 2003)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tritsch, D1
Zinglé, C1
Rohmer, M1
Grosdemange-Billiard, C1
Potapov, VD1
Bakhteeva, IV1
Borzenkov, VN1
Titareva, GM1
Wiesner, J1
Biniukov, VI1
Ostrovskiĭ, DN1
Biketov, SF1

Other Studies

2 other studies available for fosmidomycin and Escherichia coli Infections

ArticleYear
Flavonoids: true or promiscuous inhibitors of enzyme? The case of deoxyxylulose phosphate reductoisomerase.
    Bioorganic chemistry, 2015, Volume: 59

    Topics: Aldose-Ketose Isomerases; Enzyme Inhibitors; Escherichia coli; Escherichia coli Infections; Flavonoi

2015
[Effect of fosfidomycin on development of various infections in mice].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2003, Volume: 48, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Escherichia coli Infections; Fosfomycin; Mice;

2003